MAP Kinase Cascades — MCQs
Which of the following is the platinum-based chemotherapeutic agent used as first-line treatment for ovarian carcinoma?
What is the primary function of G-proteins in cellular signaling?
Knudson two-hit hypothesis is classically exemplified by
JAK-STAT pathway is seen in which of the following?
Tyrosine kinase receptor is associated with proto-oncogene -
Beta 2 receptors act via which of the following secondary messenger systems
In the mitogen activated protein kinase pathway, the activation of RAS is counteracted by
Which of the following events does NOT occur in rods in response to light
Which of the following substances is present intracellularly in muscle cells?
Which of the following enzymes inhibit the production of cAMP?
MAP Kinase Cascades Indian Medical PG Practice Questions and MCQs
Question 1: Which of the following is the platinum-based chemotherapeutic agent used as first-line treatment for ovarian carcinoma?
- A. Cyclophosphamide
- B. Methotrexate
- C. Cisplatin (Correct Answer)
- D. Dacarbazine
Explanation: ***Cisplatin*** - **Cisplatin** is a platinum-based chemotherapy drug that forms **DNA cross-links**, inhibiting DNA synthesis and leading to the death of rapidly dividing cells, making it highly effective against **ovarian carcinoma**. - It is a cornerstone of chemotherapy regimens for ovarian cancer, often used in combination with other agents such as paclitaxel. *Methotrexate* - **Methotrexate** is an **antimetabolite** that inhibits dihydrofolate reductase, thereby interfering with DNA synthesis. - While it is used in various cancers like leukemia, lymphoma, and some solid tumors (e.g., breast cancer, gestational trophoblastic disease), it is **not a primary recommended drug for ovarian carcinoma**. *Cyclophosphamide* - **Cyclophosphamide** is an **alkylating agent** that causes DNA damage, leading to cell death. - It is used in many cancers, including lymphoma, breast cancer, and some leukemias, but it is **not a first-line or primary agent for ovarian carcinoma** in contemporary treatment guidelines. *Dacarbazine* - **Dacarbazine** is an **alkylating agent** primarily used in the treatment of **malignant melanoma** and Hodgkin lymphoma. - It is **not indicated for the treatment of ovarian carcinoma**.
Question 2: What is the primary function of G-proteins in cellular signaling?
- A. Signal transducers (Correct Answer)
- B. Mediators of hormone action
- C. Molecules that bind hormones
- D. Intracellular signaling molecules
Explanation: ***Signal transducers*** - G-proteins act as **molecular switches**, converting extracellular signals received by G protein-coupled receptors (GPCRs) into intracellular responses. - They bind **GTP** in their active state and **hydrolyze it to GDP** to become inactive, regulating downstream effectors like enzymes and ion channels. *Mediators of hormone action* - While G-proteins are involved in the action of many hormones, this describes a *result* of their function rather than their fundamental role. - Their primary function is to transduce signals, which then mediates hormone effects. *Molecules that bind hormones* - **Receptors**, not G-proteins, are primarily responsible for binding hormones or other ligands. - G-proteins are activated *after* a receptor binds a ligand and undergoes a conformational change. *Intracellular signaling molecules* - This statement is true, but it's a broad category. **Signal transducers** specifically highlights their role in converting one form of signal to another. - Many molecules operate intracellularly, but G-proteins' unique role is in linking receptor activation to effector modulation.
Question 3: Knudson two-hit hypothesis is classically exemplified by
- A. Crohn disease
- B. Ulcerative colitis
- C. Retinoblastoma (Correct Answer)
- D. Melanoma
Explanation: ***Retinoblastoma*** - The **Knudson two-hit hypothesis** was **originally formulated** based on studies of **retinoblastoma** by Alfred Knudson in 1971 [1]. - It posits that **two separate mutational events** are required to inactivate **both alleles** of the **Rb tumor suppressor gene** in the same cell, leading to tumor formation [1], [2]. - This explains both **hereditary** (germline mutation + somatic mutation) and **sporadic** (two somatic mutations) forms of retinoblastoma [1], [2]. - Retinoblastoma remains the **paradigmatic example** of this hypothesis and tumor suppressor gene inactivation [2]. *Crohn disease* - This is an **inflammatory bowel disease**, not a neoplasm, with complex etiology involving genetic susceptibility, environmental factors, and immune dysregulation. - Its pathogenesis does **not follow the Knudson two-hit hypothesis**, which specifically relates to tumor suppressor gene inactivation in cancer. *Ulcerative colitis* - Similar to Crohn disease, **ulcerative colitis** is an **inflammatory bowel disease** with multifactorial etiology, not a neoplastic condition. - While chronic UC can increase colorectal cancer risk through accumulated mutations, the disease itself does **not represent the two-hit hypothesis model**. *Melanoma* - **Melanoma** is a skin cancer often linked to **UV radiation** and mutations in oncogenes like **BRAF** and tumor suppressors like **PTEN** and **CDKN2A**. [3] - While some familial melanomas involve tumor suppressor genes, melanoma is **not the classic example** used to illustrate the Knudson hypothesis—**retinoblastoma holds that distinction**. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 300. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 227-228. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 297-298.
Question 4: JAK-STAT pathway is seen in which of the following?
- A. Calcitonin
- B. Aldosterone
- C. Vasopressin
- D. Leptin (Correct Answer)
Explanation: ***Leptin*** - **Leptin** binding to its receptor activates the **JAK-STAT pathway**, regulating appetite and metabolism. - This pathway involves the phosphorylation of **STAT proteins**, which then translocate to the nucleus to induce gene expression. *Calcitonin* - **Calcitonin** activates **G protein-coupled receptors**, leading to an increase in intracellular cyclic AMP (cAMP). - Its primary role is in **calcium homeostasis**, lowering blood calcium levels. *Aldosterone* - **Aldosterone** is a steroid hormone that binds to **intracellular mineralocorticoid receptors**. - This complex then acts as a **transcription factor**, affecting gene expression in the kidneys to regulate sodium and potassium balance. *Vasopressin* - **Vasopressin** (ADH) binds to **G protein-coupled receptors** (V1 and V2 receptors). - V2 receptor activation in the kidney leads to increased **cAMP** and insertion of aquaporins, regulating water reabsorption.
Question 5: Tyrosine kinase receptor is associated with proto-oncogene -
- A. RAS (RAt Sarcoma)
- B. RET (REarranged during Transfection) (Correct Answer)
- C. RB (Retinoblastoma gene)
- D. MYC (Myelocytomatosis oncogene)
Explanation: ***RET*** - RET is a **tyrosine kinase receptor** that plays a crucial role in cell signaling and development [1][2]. - It is associated with several **neoplasms**, including medullary thyroid carcinoma and multiple endocrine neoplasia type 2 [1]. *RB* - RB (Retinoblastoma protein) is a **tumor suppressor gene**, not a proto-oncogene or receptor. - Its role is largely in regulating the **cell cycle**, particularly in preventing excessive cell growth. *RAS* - RAS is a family of **GTPase proteins** involved in transmitting signals within cells, but it is not a receptor itself [1]. - It is classified as an **oncogene**, but does not function as a tyrosine kinase receptor [2]. *MYC* - MYC is a **transcription factor** involved in cell cycle progression and growth, not a tyrosine kinase receptor [2]. - It is considered an **oncogene** that promotes cellular proliferation, but it doesn't have tyrosine kinase activity [3][4]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1097-1098. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 291-292. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. With Illustrations By, pp. 28-29. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 293-294.
Question 6: Beta 2 receptors act via which of the following secondary messenger systems
- A. Adenylate Cyclase (Correct Answer)
- B. Phospholipase C
- C. Guanylate Cyclase
- D. Direct ion channel activation
- E. Tyrosine Kinase
Explanation: ***Adenylate Cyclase*** - **Beta-2 adrenergic receptors** are G-protein coupled receptors that primarily activate the **Gs protein**. - Activation of Gs protein leads to the stimulation of **adenylate cyclase**, which converts ATP to **cAMP**, a crucial secondary messenger for various cellular responses. *Phospholipase C* - **Phospholipase C** is typically activated by **Gq protein-coupled receptors**, such as alpha-1 adrenergic receptors or M1/M3 muscarinic receptors. - Its activation leads to the production of **IP3** and **DAG**, which then trigger intracellular calcium release and protein kinase C activation, respectively. *Guanylate Cyclase* - **Guanylate cyclase** produces **cGMP** as a secondary messenger and is primarily associated with **nitric oxide signaling** (soluble guanylate cyclase) or **natriuretic peptide receptors** (particulate guanylate cyclase). - This system is distinct from the adrenergic receptor pathways. *Direct ion channel activation* - **Direct ion channel activation** occurs in **ligand-gated ion channels**, where the binding of a neurotransmitter directly opens an ion pore without the involvement of G-proteins or secondary messengers. - Examples include nicotinic acetylcholine receptors and GABA-A receptors, which are functionally different from the G-protein coupled **beta-2 receptors**. *Tyrosine Kinase* - **Tyrosine kinase** signaling is characteristic of **receptor tyrosine kinases (RTKs)**, such as insulin receptors and growth factor receptors (e.g., EGF, PDGF receptors). - These receptors undergo autophosphorylation and initiate signaling cascades independent of G-proteins, making them distinct from **beta-2 adrenergic receptors**.
Question 7: In the mitogen activated protein kinase pathway, the activation of RAS is counteracted by
- A. Inositol triphosphate
- B. GTPase activating protein (Correct Answer)
- C. Phosphatidyl inositol
- D. Protein kinase C
Explanation: ***GTPase activating protein*** - **GTPase Activating Proteins (GAPs)** facilitate the hydrolysis of **GTP bound to RAS** to GDP, converting active RAS back to its inactive state. - This inactivation is crucial for turning off the downstream signaling of the **MAPK pathway** and preventing uncontrolled cell proliferation. *Inositol triphosphate* - **Inositol triphosphate (IP3)** is a secondary messenger that triggers the release of **intracellular calcium** from the endoplasmic reticulum. - It is involved in various signaling pathways, but its primary role is not to directly counteract RAS activation. *Phosphatidyl inositol* - **Phosphatidylinositol (PI)** is a component of cell membranes and can be phosphorylated to produce various **phosphatidylinositol phosphates (PIPs)**, like **PIP2** and **PIP3**. - These molecules act as docking sites for signaling proteins but do not directly inactivate RAS. *Protein kinase C* - **Protein kinase C (PKC)** is a family of enzymes involved in signal transduction, typically activated by **diacylglycerol (DAG)** and calcium. - It phosphorylates various proteins, mediating diverse cellular responses, but it does not directly counteract the activation of RAS.
Question 8: Which of the following events does NOT occur in rods in response to light
- A. Opening of Na+ channels (Correct Answer)
- B. Activation of transducin
- C. Structural changes in rhodopsin
- D. Decreased intracellular cGMP
Explanation: ***Opening of Na+ channels*** - In response to light, **rods hyperpolarize** due to the **closure of Na+ channels**, which reduces the influx of positive ions. - The opening of Na+ channels would lead to depolarization, which is the opposite of what occurs during light detection in rods. *Activation of transducin* - Light causes **conformational changes in rhodopsin**, which in turn activates the G-protein **transducin**. - Activated transducin then goes on to activate **phosphodiesterase (PDE)** as part of the phototransduction cascade. *Structural changes in rhodopsin* - When light strikes the rhodopsin molecule, the **11-cis-retinal chromophore** isomerizes to **all-trans-retinal**. - This **conformational change** in rhodopsin is the initial step that triggers the entire phototransduction pathway. *Decreased intracellular cGMP* - Activated **phosphodiesterase (PDE)**, stimulated by transducin, hydrolyzes **cGMP to GMP**. - The reduction in **cGMP levels** leads to the closure of cGMP-gated Na+ channels, causing hyperpolarization.
Question 9: Which of the following substances is present intracellularly in muscle cells?
- A. Insulin
- B. Corticosteroid (Correct Answer)
- C. Epinephrine
- D. Glucagon
Explanation: **Explanation:** The location of a hormone receptor is primarily determined by the hormone's chemical nature (solubility). Hormones are categorized into two main groups based on their ability to cross the cell membrane. **Why Corticosteroid is Correct:** Corticosteroids (like cortisol) are **lipophilic (lipid-soluble) steroid hormones** derived from cholesterol. Because the cell membrane is a lipid bilayer, these molecules can easily diffuse through it. Once inside the muscle cell, they bind to **intracellular receptors** (specifically in the cytosol). The hormone-receptor complex then translocates into the nucleus to act as a transcription factor, altering gene expression. **Why the Other Options are Incorrect:** * **Insulin (A), Epinephrine (C), and Glucagon (D)** are all **water-soluble (hydrophilic)** hormones. * **Insulin and Glucagon** are peptide hormones, while **Epinephrine** is a catecholamine derived from amino acids. * Because they cannot cross the hydrophobic lipid bilayer, they must bind to **extracellular receptors** located on the cell surface (plasma membrane). * They trigger intracellular effects via **second messengers** (e.g., cAMP for Glucagon/Epinephrine or Tyrosine Kinase signaling for Insulin). **High-Yield NEET-PG Pearls:** * **Intracellular Receptors:** Think "Steroids & Thyroid." This includes Glucocorticoids, Mineralocorticoids, Androgens, Estrogen, Progesterone, Vitamin D, and Retinoic Acid. * **Exception:** While most steroid receptors are cytosolic, **Thyroid hormone (T3/T4)** receptors are located directly on the **chromatin in the nucleus**. * **Mechanism of Action:** Intracellular receptors typically have a **Zinc-finger motif** for DNA binding.
Question 10: Which of the following enzymes inhibit the production of cAMP?
- A. Glucagon
- B. Angiotensin II (Correct Answer)
- C. ACTH
- D. Beta-Adrenergics
Explanation: ### Explanation The production of **cyclic AMP (cAMP)** is regulated by the enzyme **Adenylyl Cyclase**, which is controlled by G-protein coupled receptors (GPCRs). **1. Why Angiotensin II is Correct:** Angiotensin II acts through two main receptor types: **AT1 and AT2**. While AT1 is primarily linked to the $G_q$ pathway (PLC-IP3/DAG), the **AT2 receptor** is coupled to **$G_i$ (inhibitory G-protein)**. Activation of $G_i$ directly inhibits Adenylyl Cyclase, leading to a decrease in intracellular cAMP levels. In the context of this question, Angiotensin II is the only ligand listed that utilizes an inhibitory pathway to decrease cAMP production. **2. Why the Other Options are Incorrect:** * **Glucagon (Option A):** Binds to glucagon receptors coupled with **$G_s$ (stimulatory G-protein)**, which activates Adenylyl Cyclase to *increase* cAMP. * **ACTH (Option C):** Adrenocorticotropic hormone binds to MC2R receptors in the adrenal cortex, which are **$G_s$-coupled**, leading to *increased* cAMP to stimulate cortisol synthesis. * **Beta-Adrenergics (Option D):** All $\beta$-receptors ($\beta_1, \beta_2, \beta_3$) are classic examples of **$G_s$-coupled** receptors that *increase* cAMP levels. **3. High-Yield Clinical Pearls for NEET-PG:** * **$G_s$ Pathway (Increases cAMP):** Glucagon, ACTH, PTH, TSH, LH, FSH, and Beta-adrenergics. * **$G_i$ Pathway (Decreases cAMP):** Somatostatin, Alpha-2 adrenergics, M2 muscarinic, and Angiotensin II (via AT2). * **$G_q$ Pathway (IP3/DAG):** Think "HAV 1 M&M" (H1, Alpha-1, V1, M1, M3) and Angiotensin II (via AT1). * **Vibrio cholerae** toxin causes permanent activation of $G_s$, while **Pertussis toxin** inhibits $G_i$; both result in pathologically high levels of cAMP.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free